Who
Michelle McMurry-Heath
Director
Company insider
Files Form 4 as: Director, Bioventus; Director, Revvity.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $750K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Jan 2022
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,015 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,265 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,015 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,265 at $0.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Sold | $105K12,000 at $8.79 | filing |
| 11 Mar 2026filed 13 Mar 2026 | BVS BioventusMedical Devices | SEC FORM 4 Sold | $105K12,000 at $8.79 | filing |
| 23 Feb 2026filed 25 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $58K600 at $97.26 | filing |
| 23 Feb 2026filed 25 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $58K600 at $97.26 | filing |
| 7 Nov 2025filed 10 Nov 2025 | BVS BioventusMedical Devices | SEC FORM 4 Sold | $131K17,701 at $7.42 | filing |
| 3 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,282 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $55K600 at $92.17 | filing |
| 30 Apr 2025filed 1 May 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,074 at $0.00 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Michelle McMurry-Heath; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.